The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
 
 
Honoraria - BMS Brazil; Merck; MSD
Consulting or Advisory Role - BMS Brazil; Merck
Speakers' Bureau - Merck; MSD
Research Funding - MSD
Travel, Accommodations, Expenses - Amgen; Merck; MSD
Pushing the accelerator and releasing the brake: A phase I dose escalation study evaluating a LAG-3 fusion protein (eftilagimod alpha), together with pembrolizumab in unresectable or metastatic melanoma.
 
Melissa A. Eastgate
Travel, Accommodations, Expenses - Bristol-Myers Squibb; Merck Sharp & Dohme
 
Victoria Atkinson
Honoraria - Bristol-Myers Squibb; Novartis
Consulting or Advisory Role - Bristol-Myers Squibb; Merck Serono; Merck Sharp & Dohme; Novartis; Pierre Fabre
Speakers' Bureau - Bristol-Myers Squibb; Merck Sharp & Dohme; Novartis; Roche/Genentech
Travel, Accommodations, Expenses - Bristol-Myers Squibb
 
Muhammad Adnan Khattak
No Relationships to Disclose
 
Amitesh Chandra Roy
Honoraria - Bristol-Myers Squibb; Merck; Pfizer
Consulting or Advisory Role - Bristol-Myers Squibb; Merck
Speakers' Bureau - Bristol-Myers Squibb; Pfizer
Research Funding - Specialised Therapeutics
Travel, Accommodations, Expenses - Bristol-Myers Squibb
 
Andrew Mark Haydon
Consulting or Advisory Role - Novartis
 
Christian Mueller
Employment - Immutep
Stock and Other Ownership Interests - Immutep
Consulting or Advisory Role - Astellas Pharma
 
Tina Dunkelmann
Employment - Immutep
 
Chrystelle Brignone
Employment - Immutep
Stock and Other Ownership Interests - Immutep
Patents, Royalties, Other Intellectual Property - Immutep
 
Frederic Triebel
Employment - Immutep
Stock and Other Ownership Interests - Immutep
Patents, Royalties, Other Intellectual Property - Immutep